Correlation Between Gilead Sciences and Rapport Therapeutics,
Can any of the company-specific risk be diversified away by investing in both Gilead Sciences and Rapport Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Gilead Sciences and Rapport Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Gilead Sciences and Rapport Therapeutics, Common, you can compare the effects of market volatilities on Gilead Sciences and Rapport Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Gilead Sciences with a short position of Rapport Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Gilead Sciences and Rapport Therapeutics,.
Diversification Opportunities for Gilead Sciences and Rapport Therapeutics,
-0.29 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Gilead and Rapport is -0.29. Overlapping area represents the amount of risk that can be diversified away by holding Gilead Sciences and Rapport Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Rapport Therapeutics, and Gilead Sciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Gilead Sciences are associated (or correlated) with Rapport Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Rapport Therapeutics, has no effect on the direction of Gilead Sciences i.e., Gilead Sciences and Rapport Therapeutics, go up and down completely randomly.
Pair Corralation between Gilead Sciences and Rapport Therapeutics,
Given the investment horizon of 90 days Gilead Sciences is expected to generate 0.24 times more return on investment than Rapport Therapeutics,. However, Gilead Sciences is 4.13 times less risky than Rapport Therapeutics,. It trades about 0.18 of its potential returns per unit of risk. Rapport Therapeutics, Common is currently generating about -0.01 per unit of risk. If you would invest 7,352 in Gilead Sciences on November 3, 2024 and sell it today you would earn a total of 2,368 from holding Gilead Sciences or generate 32.21% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Gilead Sciences vs. Rapport Therapeutics, Common
Performance |
| Timeline |
| Gilead Sciences |
| Rapport Therapeutics, |
Gilead Sciences and Rapport Therapeutics, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Gilead Sciences and Rapport Therapeutics,
The main advantage of trading using opposite Gilead Sciences and Rapport Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Gilead Sciences position performs unexpectedly, Rapport Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Rapport Therapeutics, will offset losses from the drop in Rapport Therapeutics,'s long position.| Gilead Sciences vs. Amgen Inc | Gilead Sciences vs. Merck Company | Gilead Sciences vs. AbbVie Inc | Gilead Sciences vs. Johnson Johnson |
| Rapport Therapeutics, vs. Copperbank Resources Corp | Rapport Therapeutics, vs. Molecular Partners AG | Rapport Therapeutics, vs. Centessa Pharmaceuticals PLC | Rapport Therapeutics, vs. Uber Technologies |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Other Complementary Tools
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| CEOs Directory Screen CEOs from public companies around the world | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |